Seguir
WEI ZHAO
WEI ZHAO
Postdoctoral fellow of Division of Cancer Epidemiology and Genetics, National Cancer Institute
Dirección de correo verificada de nih.gov
Título
Citado por
Citado por
Año
Comprehensive molecular portraits of human breast tumours
Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ...
Nature 490 (7418), 61-70, 2012
97712012
The cancer genome atlas pan-cancer analysis project
JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ...
Nature genetics 45 (10), 1113-1120, 2013
49742013
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ...
Cell 158 (4), 929-944, 2014
13632014
PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAnessPARP1 Inhibitors Trigger Antitumor …
J Shen, W Zhao, Z Ju, L Wang, Y Peng, M Labrie, TA Yap, GB Mills, ...
Cancer research 79 (2), 311-319, 2019
3132019
Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling
W Zhao, X He, KA Hoadley, JS Parker, DN Hayes, CM Perou
BMC genomics 15 (1), 1-11, 2014
3092014
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade
J Shen, Z Ju, W Zhao, L Wang, Y Peng, Z Ge, ZD Nagel, J Zou, C Wang, ...
Nature medicine 24 (5), 556-562, 2018
3032018
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells
JI Herschkowitz, W Zhao, M Zhang, J Usary, G Murrow, D Edwards, ...
Proceedings of the National Academy of Sciences 109 (8), 2778-2783, 2012
2412012
BRD4 inhibition is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency
C Sun, J Yin, Y Fang, J Chen, KJ Jeong, X Chen, CP Vellano, Z Ju, ...
Cancer cell 33 (3), 401-416. e8, 2018
1892018
Characterization of human cancer cell lines by reverse-phase protein arrays
J Li, W Zhao, R Akbani, W Liu, Z Ju, S Ling, CP Vellano, P Roebuck, Q Yu, ...
Cancer cell 31 (2), 225-239, 2017
1832017
Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer
K Xu, J Usary, PC Kousis, A Prat, DY Wang, JR Adams, W Wang, AJ Loch, ...
Cancer cell 21 (5), 626-641, 2012
1252012
Breast cancer quantitative proteome and proteogenomic landscape
HJ Johansson, F Socciarelli, NM Vacanti, MH Haugen, Y Zhu, I Siavelis, ...
Nature communications 10 (1), 1-14, 2019
1132019
Tumor evolution in two patients with basal-like breast cancer: a retrospective genomics study of multiple metastases
KA Hoadley, MB Siegel, KL Kanchi, CA Miller, L Ding, W Zhao, X He, ...
PLoS medicine 13 (12), e1002174, 2016
1132016
Functional variomics and network perturbation: connecting genotype to phenotype in cancer
S Yi, S Lin, Y Li, W Zhao, GB Mills, N Sahni
Nature Reviews Genetics 18 (7), 395-410, 2017
882017
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
MR Aure, V Vitelli, S Jernström, S Kumar, M Krohn, EU Due, TH Haukaas, ...
Breast Cancer Research 19 (1), 1-18, 2017
832017
Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered MicePredicting Drug Responsiveness Using GEMMs
J Usary, W Zhao, D Darr, PJ Roberts, M Liu, L Balletta, O Karginova, ...
Clinical Cancer Research 19 (17), 4889-4899, 2013
792013
Explore, visualize, and analyze functional cancer proteomic data using the cancer proteome atlas
J Li, R Akbani, W Zhao, Y Lu, JN Weinstein, GB Mills, H Liang
Cancer research 77 (21), e51-e54, 2017
772017
Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma
X Hua, W Zhao, AC Pesatori, D Consonni, NE Caporaso, T Zhang, B Zhu, ...
Nature communications 11 (1), 1-11, 2020
552020
miRNA551b-3p activates an oncostatin signaling module for the progression of triple-negative breast cancer
D Parashar, A Geethadevi, MR Aure, J Mishra, J George, C Chen, ...
Cell reports 29 (13), 4389-4406. e10, 2019
482019
Verteporfin Inhibits PD-L1 through Autophagy and the STAT1–IRF1–TRIM28 Signaling Axis, Exerting Antitumor EfficacyVerteporfin Inhibits PD-L1
J Liang, L Wang, C Wang, J Shen, B Su, AL Marisetty, D Fang, C Kassab, ...
Cancer immunology research 8 (7), 952-965, 2020
412020
Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors
L Wang, L Yang, C Wang, W Zhao, Z Ju, W Zhang, J Shen, Y Peng, C An, ...
The Journal of clinical investigation 130 (11), 5951-5966, 2020
402020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20